Thrombophilia and Fetal Loss

Benjamin Brenner

doi:10.1055/s-2003-38831

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2003; 29(2): 165-170
DOI: 10.1055/s-2003-38831

Thrombophilia and Fetal Loss

Benjamin Brenner

Director, Thrombosis and Hemostasis Unit, Department of Hematology, Rambam Medical Center, Haifa, Israel

Abstract

ABSTRACT

A large body of evidence obtained during the last 6 years suggests a significant role for inherited thrombophilia in the development of gestational vascular complications. Case-control studies demonstrated that thrombophilia is more prevalent in cohorts of women with pregnancy loss. Other complications such as preeclampsia, placental abruption, and intrauterine growth retardation may also be associated with thrombophilia. Placental pathologic findings in women with thrombophilia are hallmarked by thrombosis and fibrin deposition. Preliminary case-control studies suggest that low-molecular-weight heparins are effective in preventing pregnancy loss in women with thrombophilia and previous fetal wastage.

KEYWORDS

Thrombophilia - pregnancy - pregnancy loss - preeclampsia - low-molecular-weight heparin

Full Text

References

REFERENCES

1 Salafia C M, Minior V K, Pezzullo J C. et al . Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol . 1995; 173 1049-1057
2 Cook C L, Pridham D D. Recurrent pregnancy loss. Curr Opin Obstet Gynecol . 1995; 7 357-366
3 Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Human Reprod . 1994; 9 1328-1332
4 Hatasaka H H. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol . 1994; 37 625-634
5 Raziel A, Arieli S, Bukovsky I, Caspi E, Golan A. Investigation of the uterine cavity in recurrent aborters. Fertil Steril . 1994; 62 1080-1082
6 Sanson B J, Friederich P W, Simioni P. et al . The risk of abortion and stillbirth in antithrombin, protein C, and protein S-deficient women. Thromb Haemost . 1996; 75 387-388
7 Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost . 1995; 73 151-161
8 Rikder P M, Miletich J P, Buring J E. et al . Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med . 1998; 128 1000-1003
9 Grandone E, Margaglione M, Colaizzo D. et al . Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost . 1997; 77 822-824
10 Brenner B, Sarig G, Weiner Z. et al . Thrombophilic polymorphisms in women with fetal loss. Thromb Haemost . 1999; 82 6-9
11 Sarig G, Hoffman R, Younis J. et al . Thrombophilia is common in women with pregnancy loss and is associated with late pregnancy wastage. Fertil Steril . 2002; 77 342-347
12 Dizon-Townson D S, Kinney S, Branch D W, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol . 1997; 34 217-223
13 Roque H, Paidas M, Rebarber A. et al . Maternal thrombophilia is associated with second and third trimester fetal death (Abst). Am J Obstet Gynecol . 2001; 184 S27
14 Younis J S, Brenner B, Ohel G. et al . Activated protein C resistance and factor V Leiden mutation can with first- as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol . 2000; 43 31-35
15 Wramsby M L, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril . 2000; 74 987-991
16 Meinardi J R, Middeldorp S, de Kam J P. et al . Increased risk for fetal loss in carriers of the factor V Leiden mutation. Ann Intern Med . 1999; 130 736-739
17 Tormene D, Simioni P, Prandoni P. et al . The risk of fetal loss in family member of probands with factor V Leiden mutation. Thromb Haemost . 1999; 82 1237-1239
18 Eichinger S, Weltermann A, Philipp K. et al . Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost . 1999; 82 1232-1236
19 Clark P, Brennand J, Conkie J A. et al . Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost . 1998; 79 1166-1170
20 Kjelberg U, Andersson N E, Rosen S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost . 1999; 81 527-531
21 Tal J, Schliamser L M, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod . 1999; 14 1624-1627
22 Brenner B, Mandel H, Lanir N. et al . Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol . 1997; 97 551-554
23 Mercier E, Quere I, Mares P, Gris J C. Primary recurrent miscarriages: anti-β2-glycoprotein I IgG antibodies induce an acquired activated protein C resistance that can be detected by the modified activated protein C resistance test. Blood . 1998; 92 2993-2994
24 Souza S S, Ferriani R A, Pontes A G, Zago M A, Franco R F. Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod . 1999; 14 2448-2450
25 Martinelli I, Taioli E, Cetin I. et al . Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med . 2000; 343 1015-1018
26 de Vries I P J, Dekker G A, Huijgens P C. et al . Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol . 1997; 104 1248-1254
27 Goddijn-Wessel T A, Wouters M G, van der Molen F E. et al . Hyper-homocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Rep Biol . 1996; 66 23-29
28 Coumans A B, Huijgens P C, Jakobs C. et al . Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod . 1999; 14 211-214
29 Nelen W D M L, Blom H J, Steegers E AP, den Heijer M, Eskes T A B K. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril . 2000; 74 1196-1199
30 Züller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood . 1995; 85 3518-3523
31 Brenner B, Zivelin A, Lanir N. et al . Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C deficient newborn with massive thrombosis. Blood . 1996; 88 877-880
32 Mandel H, Brenner B, Berant M. et al . Coexistence of hereditary homocysteinuria and factor V Leiden-effect on thrombosis. N Engl J Med . 1996; 334 763-768
33 Brenner B, Vulfsons S L, Lanir N, Nahir M. Coexistence of familial antiphospholipid syndrome and factor V Leiden-impact on thrombotic diathesis. Br J Haematol . 1996; 94 166-167
34 Preston F E, Rosendaal F R, Walker I D. et al . Increased fetal loss in women with heritable thrombophilia. Lancet . 1996; 348 913-916
35 Gris J C, Quere I, Monpeyroux F. et al . Case-control study of the frequency of thrombophilic disorders in couples with late foetal-loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost . 1999; 81 891-899
36 Mousa H A, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod . 2000; 15 1830-1833
37 Dizon-Townson D S, Meline L, Nelson L M, Varner M, War K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol . 1997; 177 402-405
38 Kupferminc M J, Eldor A, Steinman N. et al . Increased frequency of genetic thrombophilias in women with complications of pregnancy. N Engl J Med . 1999; 340 9-13
39 Grandone E, Margaglione M, Colaizzo D. et al . Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol . 1998; 179 1324-1328
40 Many A, Schreiber I, Rosner S. et al . Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol . 2001; 98 1041-1044
41 Sanson B J, Lensing A WA, Prins M H, Ginsberg J S, Büller H R. The use of low molecular weight heparin in pregnancy (Abst). Blood . 1998; 92(Suppl 1) 360A
42 Gris J C, Neveu S, Tailland M L. et al . Use of low-molecular weight heparin (Enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity. Thromb Haemost . 1995; 73 362-367
43 Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis J. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost . 2000; 83 693-697
44 Nakabayashi M, Yamamoto S, Suzuki K. Analysis of thrombomodulin gene polymorphism in women with severe early-onset preeclampsia. Semin Thromb Hemost . 1999; 25 473-479
45 Franchi F, Biguzzi E, Cetin I. et al . Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol . 2001; 114 641-646
46 Yamada H, Kato E H, Ebina Y. et al . Factor XII deficiency in women with recurrent miscarriage. Gynecol Obstet Invest . 2000; 49 80-83
47 Glueck C J, Kupferminc M J, Fontaine R N. et al . Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol . 2001; 97 44-48
48 Laude I, Rongieres-Bertrand C, Boyer-Neumann C. et al . Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost . 2001; 85 18-21
49 Sarig G, Lanir N, Hoffman R, Brenner B. Protein C global assay in the evaluation of women with idiopathic pregnancy loss. Thromb Haemost . 2002; 88 32-36